AAAAAA

   
Results: 1-14 |
Results: 14
PLATELET LABELING WITH GA-67 MPO - A COMPARISON WITH IN-111-MPO
Authors: KARANIKAS G RODRIGUES M GRANEGGER S HAVLIK E SINZINGER H
Citation: G. Karanikas et al., PLATELET LABELING WITH GA-67 MPO - A COMPARISON WITH IN-111-MPO, Nuclear medicine and biology, 25(2), 1998, pp. 165-168
ADSORPTION OF TC-99M TETROFOSMIN AND TC-99M FURIFOSMIN ON PLASTIC SYRINGES
Authors: BARTOSCH R GRANEGGER S SINZINGER H
Citation: R. Bartosch et al., ADSORPTION OF TC-99M TETROFOSMIN AND TC-99M FURIFOSMIN ON PLASTIC SYRINGES, European journal of nuclear medicine, 25(9), 1998, pp. 1333-1335
ACCUMULATION OF PLATELETS AS A KEY MECHANISM OF HUMAN ERECTION
Authors: RODRIGUES M OGRADY J STACKL W GRANEGGER S SINZINGER H
Citation: M. Rodrigues et al., ACCUMULATION OF PLATELETS AS A KEY MECHANISM OF HUMAN ERECTION, Thrombosis research, 91(2), 1998, pp. 53-56
ATORVASTATIN THERAPY FOR TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN PATIENTS UNDERGOING REGULAR LDL-APHERESIS
Authors: SINZINGER H GRANEGGER S FERLITSCH A
Citation: H. Sinzinger et al., ATORVASTATIN THERAPY FOR TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN PATIENTS UNDERGOING REGULAR LDL-APHERESIS, Atherosclerosis, 134(1-2), 1997, pp. 61-61
CORRECTION OF INCREASED THROMBOGENIC POTENTIAL WITH CHOLESTEROL REDUCTION IS MAINLY DUE TO VASCULAR WALL
Authors: KARANIKAS G KRITZ H GRANEGGER S SINZINGER H
Citation: G. Karanikas et al., CORRECTION OF INCREASED THROMBOGENIC POTENTIAL WITH CHOLESTEROL REDUCTION IS MAINLY DUE TO VASCULAR WALL, Circulation, 96(6), 1997, pp. 2097-2098
UNTITLED
Authors: RODRIGUES M KARANIKAS G GRANEGGER S SINZINGER H
Citation: M. Rodrigues et al., UNTITLED, Nuclear medicine and biology, 23(8), 1996, pp. 1023-1023
BRADYKININ FORMATION DURING PROCESSING FOR CELLULAR LABELING MAY CAUSE SIDE-EFFECTS
Authors: RODRIGUES M KARANIKAS G GRANEGGER S SINZINGER H
Citation: M. Rodrigues et al., BRADYKININ FORMATION DURING PROCESSING FOR CELLULAR LABELING MAY CAUSE SIDE-EFFECTS, European journal of nuclear medicine, 23(7), 1996, pp. 857-858
SLEEP DISTURBANCE AND APPETITE LOSS AFTER LOVASTATIN
Authors: SINZINGER H MAYR F SCHMID P GRANEGGER S OGRADY J PESKAR BA
Citation: H. Sinzinger et al., SLEEP DISTURBANCE AND APPETITE LOSS AFTER LOVASTATIN, Lancet, 343(8903), 1994, pp. 973-973
LDL-APHERESIS AND CONCOMITANT ACE-INHIBITOR THERAPY
Authors: SINZINGER H BEDNAR J GRANEGGER S BLAZEK I PESKAR BA
Citation: H. Sinzinger et al., LDL-APHERESIS AND CONCOMITANT ACE-INHIBITOR THERAPY, Atherosclerosis, 105(1), 1994, pp. 115-116
IN-111 LABELED AUTOLOGOUS LOW-DENSITY LIPOPROTEINS SHOW LIPID LESION REGRESSION AND UP-REGULATION OF LIVER RECEPTOR DURING LDL-APHERESIS
Authors: SINZINGER H BEDNAR J BLAZEK I GRANEGGER S KARANIKAS G LEITINGER N PIDLICH J
Citation: H. Sinzinger et al., IN-111 LABELED AUTOLOGOUS LOW-DENSITY LIPOPROTEINS SHOW LIPID LESION REGRESSION AND UP-REGULATION OF LIVER RECEPTOR DURING LDL-APHERESIS, Circulation, 90(4), 1994, pp. 510-510
IN-111 LABELED AUTOLOGOUS LOW-DENSITY LIPOPROTEINS SHOW LIPID LESION REGRESSION AND UP-REGULATION OF LIVER RECEPTOR DURING LDL-APHERESIS
Authors: SINZINGER H BEDNAR J BLAZEK I GRANEGGER S KARANIKAS G LEITINGER N PIDLICH J
Citation: H. Sinzinger et al., IN-111 LABELED AUTOLOGOUS LOW-DENSITY LIPOPROTEINS SHOW LIPID LESION REGRESSION AND UP-REGULATION OF LIVER RECEPTOR DURING LDL-APHERESIS, Circulation, 90(4), 1994, pp. 510-510
SEVERE ANAPHYLACTOID REACTION IN A PATIENT OF ACE-INHIBITORS UNDERGOING DEXTRAN-SULFATE LDL-APHERESIS DUE TO (BRADY)KININ ACCUMULATION
Authors: SINZINGER H GRANEGGER S PESKAR BA
Citation: H. Sinzinger et al., SEVERE ANAPHYLACTOID REACTION IN A PATIENT OF ACE-INHIBITORS UNDERGOING DEXTRAN-SULFATE LDL-APHERESIS DUE TO (BRADY)KININ ACCUMULATION, Thrombosis and haemostasis, 69(6), 1993, pp. 883-883
IMPROVED PLATELET 111IN-OXINE LABELING DATA IN PATIENTS WITH HYPOBETALIPOPROTEINEMIA
Authors: GRANEGGER S PIRICH C NEUMANN I SINZINGER H
Citation: S. Granegger et al., IMPROVED PLATELET 111IN-OXINE LABELING DATA IN PATIENTS WITH HYPOBETALIPOPROTEINEMIA, Thrombosis and haemostasis, 69(6), 1993, pp. 884-884
N-3 FATTY-ACID SUPPLEMENTATION IMPROVES IN-VITRO 111IN-OXINE PLATELETLABELING DATA IN HYPERCHOLESTEROLEMICS MORE THAN IN NORMOCHOLESTEROLEMICS
Authors: GRANEGGER S GASZO A PIRICH C NEUMANN I HORROBIN D SINZINGER H
Citation: S. Granegger et al., N-3 FATTY-ACID SUPPLEMENTATION IMPROVES IN-VITRO 111IN-OXINE PLATELETLABELING DATA IN HYPERCHOLESTEROLEMICS MORE THAN IN NORMOCHOLESTEROLEMICS, Thrombosis and haemostasis, 69(6), 1993, pp. 885-885
Risultati: 1-14 |